Month: May 2021

A new study about the reprogramming of lipid metabolism to combat cellular hepatocarcinoma

A work coordinated by Isabel Fabregat – group leader of TGF-β and Cancer group at IDIBELL and CIBEREHD – University of Barcelona – studies the reprogramming of lipid metabolism and provides new perspectives for the possible use of fatty acids and mitochondrial oxidative metabolism in new pharmacological approaches to decrease the metastasis of hepatocellular carcinoma.

IDIBELL researchers identify a brain region that predicts the evolution of apathy in Huntington’s patients

The atrophy of a specific region of the cerebral cortex is related to the appearance of apathy in Huntington’s patients, a neurodegenerative disease that affects motor and cognitive function. This is the conclusion of a study of the Bellvitge Biomedical Research Institute (IDIBELL) published in the Movement Disorders journal.

Researchers identify a possible therapy against Rendu-Osler disease

Research It is a rare disease that causes malformations in blood vessels. The study has discovered the implication of a protein in the development of the pathology.

Scroll to Top